Medline Inc. (MDLN)

35.28 +1.82% (+0.63)

Over 5Y: -14.0%

2026-08-28
40 50
Dec Feb Apr Jun Aug

Financials Quarterly

Q1 '25 — Revenue: 6.6B Q1 '25 — Operating Cash Flow: 682M Q1 '25 — Free Cash Flow: 584M Q1 '25 — Net Income: 319M Q2 '25 — Revenue: 6.9B Q2 '25 — Operating Cash Flow: 197M Q2 '25 — Free Cash Flow: 87M Q2 '25 — Net Income: 329M Q1 '26 — Revenue: 7.4B Q1 '26 — Operating Cash Flow: 412M Q1 '26 — Free Cash Flow: 316M Q1 '26 — Net Income: 239M Q2 '26 — Revenue: 7.7B Q2 '26 — Operating Cash Flow: 715M Q2 '26 — Free Cash Flow: 604M Q2 '26 — Net Income: 139M 0 2B 4B 6B 8B
Q1 '25 Q2 '25 Q1 '26 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2025-12-31, reported in USD. The newest fact in the filings is dated 2026-06-27, 64 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.7
SBC / sales 0.27%
OE margin 4.3%
ROIC 8.1%
Accruals -3.9%
FCF margin 4.6%
Gross margin 26.4%
OCF margin 6.1%
ROA 0.5%
ROCE 6.0%
OCF / EBIT 0.79×
ROE 1.7%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

9.1
Segment HHI 0.58 HHI
RPO / sales —
RPO growth —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

5.1
ND/EBITDA —
Payout 0.0%
Quick ratio 2.6×
F-score 6.8 pts
Cash / Debt 0.21×
Debt / Eq 1.1×
Net debt / Eq 0.86×
Debt payback 7.6 yr
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.4
Sales/sh Y/Y +11.5%
EBIT CAGR +33.0%
EBIT Y/Y +3.1%
Div. growth —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —
Sales Q/Q —
Shares change —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.